Complicated Skin and Skin Structure Infection (cSSSI)

† Adult patients with cSSSs were enrolled in a randomized, multicenter, international, double-blind trial. The study evaluated meropenem at doses of 500 mg every 8 hours and imipenem/cilastatin at doses of 500 mg every 8 hours and compared the clinical response between treatment groups in the clinically evaluable population at the follow-up (test-of-cure) visit.
‡ (n = number of patients)

§ Patients may have more than 1 pretreatment pathogen.
// (n=number of patients with satisfactory response; N=number of patients in the clinically evaluable population or subgroup within treatment groups)

Next Page > Intra-abdominal infection (IAI)